1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Histoplasmosis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Amphotericin B 1.2.3 Itraconazole 1.2.4 Ketoconazole 1.2.5 Other 1.3 Market by Distribution Channel 1.3.1 Global Histoplasmosis Treatment Market Share by Distribution Channel: 2017 VS 2021 VS 2028 1.3.2 Hospitals Pharmacies 1.3.3 Drug stores and retail pharmacy 1.3.4 E-commerce 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Histoplasmosis Treatment Market Perspective (2017-2028) 2.2 Histoplasmosis Treatment Growth Trends by Region 2.2.1 Histoplasmosis Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Histoplasmosis Treatment Historic Market Size by Region (2017-2022) 2.2.3 Histoplasmosis Treatment Forecasted Market Size by Region (2023-2028) 2.3 Histoplasmosis Treatment Market Dynamics 2.3.1 Histoplasmosis Treatment Industry Trends 2.3.2 Histoplasmosis Treatment Market Drivers 2.3.3 Histoplasmosis Treatment Market Challenges 2.3.4 Histoplasmosis Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Histoplasmosis Treatment Players by Revenue 3.1.1 Global Top Histoplasmosis Treatment Players by Revenue (2017-2022) 3.1.2 Global Histoplasmosis Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Histoplasmosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Histoplasmosis Treatment Revenue 3.4 Global Histoplasmosis Treatment Market Concentration Ratio 3.4.1 Global Histoplasmosis Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Histoplasmosis Treatment Revenue in 2021 3.5 Histoplasmosis Treatment Key Players Head office and Area Served 3.6 Key Players Histoplasmosis Treatment Product Solution and Service 3.7 Date of Enter into Histoplasmosis Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Histoplasmosis Treatment Breakdown Data by Type 4.1 Global Histoplasmosis Treatment Historic Market Size by Type (2017-2022) 4.2 Global Histoplasmosis Treatment Forecasted Market Size by Type (2023-2028) 5 Histoplasmosis Treatment Breakdown Data by Distribution Channel 5.1 Global Histoplasmosis Treatment Historic Market Size by Distribution Channel (2017-2022) 5.2 Global Histoplasmosis Treatment Forecasted Market Size by Distribution Channel (2023-2028) 6 North America 6.1 North America Histoplasmosis Treatment Market Size (2017-2028) 6.2 North America Histoplasmosis Treatment Market Size by Country (2017-2022) 6.3 North America Histoplasmosis Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Histoplasmosis Treatment Market Size (2017-2028) 7.2 Europe Histoplasmosis Treatment Market Size by Country (2017-2022) 7.3 Europe Histoplasmosis Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Histoplasmosis Treatment Market Size (2017-2028) 8.2 Asia-Pacific Histoplasmosis Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Histoplasmosis Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Histoplasmosis Treatment Market Size (2017-2028) 9.2 Latin America Histoplasmosis Treatment Market Size by Country (2017-2022) 9.3 Latin America Histoplasmosis Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Histoplasmosis Treatment Market Size (2017-2028) 10.2 Middle East & Africa Histoplasmosis Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Histoplasmosis Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Bristol Myers Squibb 11.1.1 Bristol Myers Squibb Company Detail 11.1.2 Bristol Myers Squibb Business Overview 11.1.3 Bristol Myers Squibb Histoplasmosis Treatment Introduction 11.1.4 Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2017-2022) 11.1.5 Bristol Myers Squibb Recent Development 11.2 Sigma tau pharmaceuticals Inc. 11.2.1 Sigma tau pharmaceuticals Inc. Company Detail 11.2.2 Sigma tau pharmaceuticals Inc. Business Overview 11.2.3 Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Introduction 11.2.4 Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) 11.2.5 Sigma tau pharmaceuticals Inc. Recent Development 11.3 Three rivers pharmaceuticals 11.3.1 Three rivers pharmaceuticals Company Detail 11.3.2 Three rivers pharmaceuticals Business Overview 11.3.3 Three rivers pharmaceuticals Histoplasmosis Treatment Introduction 11.3.4 Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2017-2022) 11.3.5 Three rivers pharmaceuticals Recent Development 11.4 Astellas pharma US Inc. 11.4.1 Astellas pharma US Inc. Company Detail 11.4.2 Astellas pharma US Inc. Business Overview 11.4.3 Astellas pharma US Inc. Histoplasmosis Treatment Introduction 11.4.4 Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) 11.4.5 Astellas pharma US Inc. Recent Development 11.5 Abbott laboratories 11.5.1 Abbott laboratories Company Detail 11.5.2 Abbott laboratories Business Overview 11.5.3 Abbott laboratories Histoplasmosis Treatment Introduction 11.5.4 Abbott laboratories Revenue in Histoplasmosis Treatment Business (2017-2022) 11.5.5 Abbott laboratories Recent Development 11.6 Abraxis pharmaceutical products 11.6.1 Abraxis pharmaceutical products Company Detail 11.6.2 Abraxis pharmaceutical products Business Overview 11.6.3 Abraxis pharmaceutical products Histoplasmosis Treatment Introduction 11.6.4 Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2017-2022) 11.6.5 Abraxis pharmaceutical products Recent Development 11.7 Teva parenteral medicines Inc. 11.7.1 Teva parenteral medicines Inc. Company Detail 11.7.2 Teva parenteral medicines Inc. Business Overview 11.7.3 Teva parenteral medicines Inc. Histoplasmosis Treatment Introduction 11.7.4 Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) 11.7.5 Teva parenteral medicines Inc. Recent Development 11.8 X gen pharmaceuticals Inc. 11.8.1 X gen pharmaceuticals Inc. Company Detail 11.8.2 X gen pharmaceuticals Inc. Business Overview 11.8.3 X gen pharmaceuticals Inc. Histoplasmosis Treatment Introduction 11.8.4 X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) 11.8.5 X gen pharmaceuticals Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Histoplasmosis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Amphotericin B Table 3. Key Players of Itraconazole Table 4. Key Players of Ketoconazole Table 5. Key Players of Other Table 6. Global Histoplasmosis Treatment Market Size Growth by Distribution Channel (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Histoplasmosis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Histoplasmosis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Histoplasmosis Treatment Market Share by Region (2017-2022) Table 10. Global Histoplasmosis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Histoplasmosis Treatment Market Share by Region (2023-2028) Table 12. Histoplasmosis Treatment Market Trends Table 13. Histoplasmosis Treatment Market Drivers Table 14. Histoplasmosis Treatment Market Challenges Table 15. Histoplasmosis Treatment Market Restraints Table 16. Global Histoplasmosis Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Histoplasmosis Treatment Market Share by Players (2017-2022) Table 18. Global Top Histoplasmosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histoplasmosis Treatment as of 2021) Table 19. Ranking of Global Top Histoplasmosis Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Histoplasmosis Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Histoplasmosis Treatment Product Solution and Service Table 23. Date of Enter into Histoplasmosis Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Histoplasmosis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Histoplasmosis Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Histoplasmosis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Histoplasmosis Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Histoplasmosis Treatment Market Size by Distribution Channel (2017-2022) & (US$ Million) Table 30. Global Histoplasmosis Treatment Revenue Market Share by Distribution Channel (2017-2022) Table 31. Global Histoplasmosis Treatment Forecasted Market Size by Distribution Channel (2023-2028) & (US$ Million) Table 32. Global Histoplasmosis Treatment Revenue Market Share by Distribution Channel (2023-2028) Table 33. North America Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Histoplasmosis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Histoplasmosis Treatment Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Histoplasmosis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Histoplasmosis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. Bristol Myers Squibb Company Detail Table 44. Bristol Myers Squibb Business Overview Table 45. Bristol Myers Squibb Histoplasmosis Treatment Product Table 46. Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 47. Bristol Myers Squibb Recent Development Table 48. Sigma tau pharmaceuticals Inc. Company Detail Table 49. Sigma tau pharmaceuticals Inc. Business Overview Table 50. Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Product Table 51. Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 52. Sigma tau pharmaceuticals Inc. Recent Development Table 53. Three rivers pharmaceuticals Company Detail Table 54. Three rivers pharmaceuticals Business Overview Table 55. Three rivers pharmaceuticals Histoplasmosis Treatment Product Table 56. Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 57. Three rivers pharmaceuticals Recent Development Table 58. Astellas pharma US Inc. Company Detail Table 59. Astellas pharma US Inc. Business Overview Table 60. Astellas pharma US Inc. Histoplasmosis Treatment Product Table 61. Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 62. Astellas pharma US Inc. Recent Development Table 63. Abbott laboratories Company Detail Table 64. Abbott laboratories Business Overview Table 65. Abbott laboratories Histoplasmosis Treatment Product Table 66. Abbott laboratories Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 67. Abbott laboratories Recent Development Table 68. Abraxis pharmaceutical products Company Detail Table 69. Abraxis pharmaceutical products Business Overview Table 70. Abraxis pharmaceutical products Histoplasmosis Treatment Product Table 71. Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 72. Abraxis pharmaceutical products Recent Development Table 73. Teva parenteral medicines Inc. Company Detail Table 74. Teva parenteral medicines Inc. Business Overview Table 75. Teva parenteral medicines Inc. Histoplasmosis Treatment Product Table 76. Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 77. Teva parenteral medicines Inc. Recent Development Table 78. X gen pharmaceuticals Inc. Company Detail Table 79. X gen pharmaceuticals Inc. Business Overview Table 80. X gen pharmaceuticals Inc. Histoplasmosis Treatment Product Table 81. X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2017-2022) & (US$ Million) Table 82. X gen pharmaceuticals Inc. Recent Development Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Global Histoplasmosis Treatment Market Share by Type: 2021 VS 2028 Figure 2. Amphotericin B Features Figure 3. Itraconazole Features Figure 4. Ketoconazole Features Figure 5. Other Features Figure 6. Global Histoplasmosis Treatment Market Share by Distribution Channel in 2021 & 2028 Figure 7. Hospitals Pharmacies Case Studies Figure 8. Drug stores and retail pharmacy Case Studies Figure 9. E-commerce Case Studies Figure 10. Other Case Studies Figure 11. Histoplasmosis Treatment Report Years Considered Figure 12. Global Histoplasmosis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Histoplasmosis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Histoplasmosis Treatment Market Share by Region: 2021 VS 2028 Figure 15. Global Histoplasmosis Treatment Market Share by Players in 2021 Figure 16. Global Top Histoplasmosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histoplasmosis Treatment as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Histoplasmosis Treatment Revenue in 2021 Figure 18. North America Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Histoplasmosis Treatment Market Share by Country (2017-2028) Figure 20. United States Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Histoplasmosis Treatment Market Share by Country (2017-2028) Figure 24. Germany Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Histoplasmosis Treatment Market Share by Region (2017-2028) Figure 32. China Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Histoplasmosis Treatment Market Share by Country (2017-2028) Figure 40. Mexico Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Histoplasmosis Treatment Market Share by Country (2017-2028) Figure 44. Turkey Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Histoplasmosis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Bristol Myers Squibb Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 47. Sigma tau pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 48. Three rivers pharmaceuticals Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 49. Astellas pharma US Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 50. Abbott laboratories Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 51. Abraxis pharmaceutical products Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 52. Teva parenteral medicines Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 53. X gen pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2017-2022) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Bristol Myers Squibb Sigma tau pharmaceuticals Inc. Three rivers pharmaceuticals Astellas pharma US Inc. Abbott laboratories Abraxis pharmaceutical products Teva parenteral medicines Inc. X gen pharmaceuticals Inc.